Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema

Affiliations

• ¹ Department of Allergology, Medical University of Sofia, Sofia, Bulgaria. Electronic address: anna.valerieva@gmail.com.
• ² Department of Allergology, Medical University of Sofia, Sofia, Bulgaria.
• ³ Centre for Hereditary Angioedema, Department of Pediatrics, Jessenius Faculty of Medicine in Martin, Martin, Slovakia; Comenius University in Bratislava and University Hospital, Bratislava, Slovakia.
• ⁴ Comenius University in Bratislava and University Hospital, Bratislava, Slovakia.
• ⁵ Department of Immunology, 2nd Medical School Charles University and University Hospital Motol, Prague, Czech Republic.
• ⁶ Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
• ⁷ Clinic of Allergy and Immunology, Clinical Centre of Serbia, and School of Medicine, University of Belgrade, Belgrade, Serbia.
• ⁸ Pharming Group NV, Leiden, The Netherlands.
• ⁹ University Saints Cyril and Methodius School of Medicine, Skopje, North Macedonia.
• ¹⁰ Ear, Nose and Throat Department, General Hospital Sibenik, Sibenik, Croatia.
• ¹¹ Asthma and Allergy Associates PC, Colorado Springs, Colo.
• ¹² Midwest Immunology Clinic, Plymouth, Minn.
• ¹³ Denver Allergy and Asthma Associates, Lakewood, Colo.
• ¹⁴ AIRE Medical Group, Inc, and University of California Los Angeles School of Medicine, Los Angeles, Calif.
• ¹⁵ Lincoln Family Medicine Program and Union College, Physician, Allergy, Asthma & Immunology Associates PC, Lincoln, Neb.
• ¹⁶ Yale School of Medicine, New Haven, Conn.
• ¹⁷ ASST Fatebenefratelli Sacco University of Milan, Milan, Italy.